NOF Tip for 10 May – Osteoporosis Medications

Diet and exercise are not always enough to prevent fractures.  Medications are needed if you are fracturing or BMD is falling despite your best efforts. We have many posts about when...

Evenity is a Really Different Anabolic

We now have a third anabolic medication to build new bone.  Evenity is really different from the other anabolics, Forteo (teriparatide) and Tymlos (abaloparatide).  Forteo and Tymlos are daily shots based...

Treat to Target #6 – Treatment

Our goal is NO NEW FRACTURES.  Therefore, Treat to Target means a FRAX score of <20% for “major osteoporotic” and <3% for hip fracture.  Alternately, T-score of better than -1.5 if...

A New Anabolic – Tymlos

The FDA approved Tymlos (Abaloparatide) in June for use in women diagnosed with osteoporosis.  Unfortunately most patients are unlikely to obtain insurance coverage for Tymlos until January or February 2018. Tymlos...

“Treat to Target” and “Use VFA” in 2017

Clinical Osteoporosis 2017, NOF and ISCD joint meeting had a different emphasis this year.  Fracture Risk, rather than Bone Mineral Density (BMD) is now the key metric.  Several speakers emphasizd...

Use the Anabolic, Forteo, First => Then Use an Antiresorptive

Recent studies have shown that the order in which we use osteoporosis medications matters.  Traditionally most docs have used Antirsorptives first to preserve bone.  All osteoporosis medications except one are Antiresorptives....

Forteo Treats Atypical Fractures of the Femur

Patients, Primary Care Docs, and Orthopedic Surgeons all worry about bone surgery while on Osteoporosis Medications.  They also worry about Atypical Fractures of the Femur (AFF).  There is one medication...